Related Experiment Video
Updated: May 4, 2026
10:32
Surgical Tips and Tricks for Performing Porcine Pancreas Transplantation
Published on: July 20, 2022
2.2K
Recent advances in pancreatic transplantation
Aphrodite Iacovidou1, Nadey Hakim
1Imperial College London - Department of Surgery and Cancer, St Mary's Hospital, Praed Street London, London W2 1NY, United Kingdom.
Summary
Pancreatic transplantation offers significant benefits for diabetes patients, improving glycemic control and reducing complications. This therapy is the only current method for achieving normal glucose levels without insulin injections.
Area of Science:
- Transplantation immunology
- Endocrinology
- Surgical innovation
Background:
- Pancreatic transplantation has evolved significantly over 25 years.
- It offers a promising treatment for diabetes and associated multiorgan complications.
- Transplanted patients demonstrate improved glycemic, blood pressure, and lipid control, alongside reversal of microvascular complications and reduced cardiovascular risk.
Purpose of the Study:
- To explore advancements in surgical techniques, patient selection, and immunosuppressant therapy for pancreatic transplants.
- To understand the factors contributing to improved outcomes and reduced complications in pancreatic transplantation.
- To highlight the current status and future potential of pancreatic transplantation in managing diabetes.
Main Methods:
- Review of surgical technique advancements, including islet cell transplantation.
- Analysis of evolving patient selection criteria.
- Examination of progress in immunosuppressant therapies.
- Evaluation of post-transplant survival rates and complication reduction.
Main Results:
- Over 32,000 pancreatic transplant procedures have been performed globally.
- One-year and five-year post-transplant survival rates are 95% and 83%, respectively.
- New techniques like islet cell implantation show promising early results.
Conclusions:
- Pancreatic transplantation has demonstrated substantial progress, leading to improved patient outcomes.
- Continuous advancements in surgical methods, patient management, and immunosuppression are key drivers of success.
- Pancreatic transplantation remains the sole existing therapy capable of normalizing glucose metabolism without the need for exogenous insulin.
